Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication

• Annie Guérin ,

  * E-mail: annie.guerin@analysisgroup.com

  Affiliation Analysis Group, Inc., Montreal, Quebec, Canada

  ⨯
• Reema Mody,

  Affiliation Takeda Pharmaceuticals International, Inc., Health Economics and Outcomes Research, Deerfield, Illinois, United States of America

  ⨯
• Valerie Carter,

  Affiliation Analysis Group, Inc., Montreal, Quebec, Canada

  ⨯
• Charles Ayas,

  Affiliation Analysis Group, Inc., Montreal, Quebec, Canada

  ⨯
• Haridarshan Patel,

  Affiliation Immensity Consulting, Inc., Chicago, Illinois, United States of America

  ⨯
• Karen Lasch,

  Affiliation Takeda Pharmaceuticals International, Inc., Health Economics and Outcomes Research, Deerfield, Illinois, United States of America

  ⨯
• Eric Wu

  Affiliation Analysis Group, Inc., Boston, Massachusetts, United States of America

  ⨯